Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
M&A mergers and acquisitions business deal

Buffalo’s 2nd largest diagnostic imaging center operator on why it sold to private equity

Founded in 1959, Southtowns Radiology announced in November that it was unloading its imaging center business to Atlanta-based Rezolut. 

artificial intelligence AI in government

‘First federal CIO’ gives 3 reality checks on governmental AI

The White House’s Office of Management and Budget recently released final guidance for the use of AI by executive-branch departments and agencies.

Thumbnail

100+ groups ask OCR for clarification on HIPAA requirements after Change Healthcare hack

In a letter dated May 20, a number of medical associations and physicians groups ask the OCR to force UnitedHealth Group to follow through on notifying patients that their data was taken by hackers.

doctor in handcuffs after being arrested

Twin doctors plead guilty in $45M insurance fraud scheme

Desi Barroga and Deno Barroga allegedly prescribed opiates to patients in exchange for false statements to insurers.

Hospira, an Illinois-based pharmaceutical and medical device company owned by Pfizer, has issued a voluntary recall of two different drugs due to ongoing safety issues. The recall includes specific lots of labetalol hydrochloride injections and buprenorphine hydrochloride injections. Labetalol hydrochloride injections are used to control blood pressure in patients with severe hypertension.

Pfizer recalls 2 drugs, including 1 for hypertension, over safety concerns

The recall was put in place due to a leak risk that could make the therapies less effective and potentially lead to an infection. 

the words "FDA recall" on a board

Dozens of injuries trigger FDA recall of over 50,000 implantable tissue marking devices

The Class I recall, which is the most serious recall the FDA issues, comes after numerous adverse events and complications linked to the radiographic markers were reported.  

BioZorb 3D bioabsorbable marker Hologic

Hologic recalling breast care devices after 71 injuries, FDA says

UPDATED: The alert pertains to the BioZorb and BioZorb LP radiographic markers, implanted in soft tissue to indicate the site for radiation therapy or other medical procedures. 

'Too many cooks in the kitchen': How AI is both helpful and a hindrance to radiologists

Recent research suggests that, in many cases, radiologist performance only improves minimally with AI assistance.

Displaying 2657 - 2664 of 15153
Design by Adaptive Theme